Optimizing the Targeting of Mouse Parvovirus 1 to Murine Melanoma Selects for Recombinant Genomes and Novel Mutations in the Viral Capsid Gene

Combining virus-enhanced immunogenicity with direct delivery of immunomodulatory molecules would represent a novel treatment modality for melanoma, and would require development of new viral vectors capable of targeting melanoma cells preferentially. Here we explore the use of rodent protoparvovirus...

Descripción completa

Detalles Bibliográficos
Autores principales: Marr, Matthew, D’Abramo, Anthony, Pittman, Nikea, Agbandje-McKenna, Mavis, Cotmore, Susan, Tattersall, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850361/
https://www.ncbi.nlm.nih.gov/pubmed/29385689
http://dx.doi.org/10.3390/v10020054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850361/
https://www.ncbi.nlm.nih.gov/pubmed/29385689
http://dx.doi.org/10.3390/v10020054

Ejemplares similares